Editorial: Purinergic signaling in metabolic diseases and inflammation pharmacology.
作者信息
Sánchez-Melgar Alejandro, Sanz Juana Maria, Giuliani Anna Lisa
机构信息
Department of Inorganic, Organic Chemistry and Biochemistry, Faculty of Chemical Sciences and Technologies, Institute of Biomedicine (IB-UCLM), Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), University of Castilla-La Mancha, Ciudad Real, Spain.
Department of Chemistry and Pharmaceutical Science, University of Ferrara, Ferrara, Italy.
出版信息
Front Pharmacol. 2025 Jun 19;16:1631388. doi: 10.3389/fphar.2025.1631388. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Purinergic signaling in metabolic diseases and inflammation pharmacology.
Front Pharmacol. 2025 Jun 19;16:1631388. doi: 10.3389/fphar.2025.1631388. eCollection 2025.
2
A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19.
Int J Mol Sci. 2023 Apr 26;24(9):7865. doi: 10.3390/ijms24097865.
3
Extracellular Vesicles and Purinergic Signaling in Alzheimer's Disease-Joining Forces for Novel Therapeutic Approach.
Brain Sci. 2025 May 26;15(6):570. doi: 10.3390/brainsci15060570.
4
Mitochondrial dysfunction in the regulation of aging and aging-related diseases.
Cell Commun Signal. 2025 Jun 19;23(1):290. doi: 10.1186/s12964-025-02308-7.
5
Editorial: Purinergic Pharmacology.
Front Pharmacol. 2019 Jan 23;10:21. doi: 10.3389/fphar.2019.00021. eCollection 2019.
6
A Bibliometric Analysis of P2X7R in Cardiovascular Diseases From 2005 to 2024.
Curr Cardiol Rev. 2025 Jun 25. doi: 10.2174/011573403X376830250619055153.
7
Editorial: Purinergic pharmacology, Volume II.
Front Pharmacol. 2023 May 16;14:1200187. doi: 10.3389/fphar.2023.1200187. eCollection 2023.
8
Purinergic signaling, dyslipidemia and inflammatory disease.
Cell Physiol Biochem. 2012;30(6):1333-9. doi: 10.1159/000343322. Epub 2012 Oct 23.
9
P2 purinergic receptor expression and function in tumor-related immune cells.
Purinergic Signal. 2024 Oct 10. doi: 10.1007/s11302-024-10054-7.
10
Mechanism of Guigan Longmu Decoction in the Treatment of Arrhythmias Based on Network Pharmacology and Untargeted Metabolomics Assays.
Comb Chem High Throughput Screen. 2025;28(8):1384-1401. doi: 10.2174/0113862073293313240519161145.
本文引用的文献
1
Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation.
J Neuroinflammation. 2025 Feb 15;22(1):39. doi: 10.1186/s12974-025-03360-3.
2
Adipose tissue inflammation and metabolic dysfunction in obesity.
Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C375-C391. doi: 10.1152/ajpcell.00379.2020. Epub 2020 Dec 23.
3
The Role of Inflammation in Age-Related Sarcopenia.
Front Physiol. 2017 Dec 12;8:1045. doi: 10.3389/fphys.2017.01045. eCollection 2017.
4
The P2X7 receptor: A main player in inflammation.
Biochem Pharmacol. 2018 May;151:234-244. doi: 10.1016/j.bcp.2017.12.021. Epub 2017 Dec 27.
5
Role of neuroinflammation in neurodegeneration: new insights.
Alzheimers Res Ther. 2017 Mar 4;9(1):14. doi: 10.1186/s13195-017-0241-2.
6
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.
Nat Rev Endocrinol. 2015 Apr;11(4):228-41. doi: 10.1038/nrendo.2015.10. Epub 2015 Feb 17.
7
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.
Lancet Diabetes Endocrinol. 2014 Oct;2(10):819-29. doi: 10.1016/S2213-8587(14)70034-8. Epub 2014 Mar 6.
8
Inflammation and metabolic disorders.
Nature. 2006 Dec 14;444(7121):860-7. doi: 10.1038/nature05485.
Zotero 插件